Anita Katharina Wagner is Associate Professor in the Department of Population Medicine at Harvard Medical School and the Harvard Pilgrim Health Care Institute in Boston, MA, USA.
For the past two decades, Dr. Wagner has contributed to or led applied research and capacity strengthening collaborations to improve—from a health systems perspective—medicines availability, access, affordability, and use, in the United States and in low and middle-income countries (LMIC). More recently, her work focuses on health system questions around cancer therapies.
She founded and directs the global Medicines and Insurance Coverage (MedIC) Initiative, which aims to support LMIC system leaders and operational staff in the design, implementation, evaluation, and routine monitoring of evidence-informed medicines policies and programs. More than 200 professionals from governments, academia, and other organizations in more than 20 countries have participated in MedIC Courses on Medicines in Health Systems. In 2016, the team launched the first online Course on Medicines in Health Systems Working Toward Universal Health Coverage on the World Bank Open Learning Campus.
Dr. Wagner also serves as a pharmacoepidemiologist on the FDA’s Sentinel Initiative, a national system that tracks the safety of pharmaceuticals in the United States.
Dr. Wagner received her Master of Public Health degree in international health and Doctor of Public Health degree in epidemiology from the Harvard School of Public Health. She holds a doctorate in clinical pharmacy from the Massachusetts College of Pharmacy and Allied Health Sciences and a German master-equivalent degree in pharmacy.
Essential Medicines for Universal Health Coverage. Wirtz V, Hogerzeil HV, Gray AL, Bigdeli M, de Joncheere CP, Ewen MA, Gyansa-Lutterodt M, Sun J, Luiza VL, Mbindyo RM, Moeller H, Moucheraud C, Pecoul B, Rago L, Rashidian A, Ross-Degnan D, Stephens PN, Teerawattananon Y, 't Hoen EFM, Wagner AK, Yadav P, Reich M. The Lancet. 2017Jan 28;389 (10067): 403-476.
Caitlin Lupton (interim)